TGF-β在腹膜型子宫内膜异位症病理生理学中的作用
本文为描述性综述,检索Pubmed 1995至2016年文献,最终纳入95项研究,聚焦腹膜型子宫内膜异位症。综述显示,子宫内膜异位症女性腹膜液、血清、异位内膜和腹膜中TGF-β1升高,TGF-β1缺失小鼠病灶生长减少;TGF-β信号与免疫细胞活性降低、异位内膜细胞存活、黏附、侵袭和增殖增加及新生血管形成相关。作者认为TGF-β1在腹膜型子宫内膜异位症病灶发展中起主要作用,靶向该通路可能具有治疗潜力。
要点
- 子宫内膜异位症女性腹膜液、血清、异位内膜和腹膜中TGF-β1较无子宫内膜异位症女性升高。
- TGF-β1缺失小鼠较野生型对照子宫内膜异位症病灶生长减少。
- TGF-β信号与腹膜免疫细胞活性降低及异位内膜细胞存活、黏附、侵袭、增殖增加相关。
核心结论
- 这些研究提示TGF-β1在腹膜型子宫内膜异位症病灶发展中起主要作用,靶向该通路可能具有治疗潜力。
研究设计与样本
- 描述性综述,检索Pubmed数据库1995至2016年发表的文献,初检识别99项研究,最终纳入95项研究。
- 纳入研究仅聚焦腹膜型子宫内膜异位症,因越来越多证据提示卵巢型和深部子宫内膜异位症可能具有不同的病理生理学。
主要发现
- 子宫内膜异位症女性腹膜液、血清、异位内膜和腹膜中TGF-β1较无子宫内膜异位症女性升高。
- TGF-β1缺失小鼠较野生型对照子宫内膜异位症病灶生长减少。
- 小鼠和女性研究提示,TGF-β配体水平升高与腹膜内免疫细胞活性降低及病灶发展过程中异位子宫内膜细胞存活、黏附、侵袭和增殖增加相关。
- TGF-β1与异位子宫内膜和腹膜细胞代谢改变及新生血管形成启动相关,进一步促进子宫内膜异位症病灶发展。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endometriosis is estimated to affect 6-10% of women of reproductive age and it is associated with chronic pelvic pain, dysmenorrhoea and subfertility. It is currently managed surgically or medically but symptoms recur in up to 75% of cases and available medical treatments have undesirable side effects. Endometriosis is defined as the presence of endometrial tissue outside the uterus with lesions typically found on the peritoneum. The aetiology of endometriosis is uncertain but there is increasing evidence that transforming growth factor (TGF)-β plays a major role. OBJECTIVE AND RATIONALE: A descriptive review was undertaken of the published literature on the expression pattern of TGF-β ligands and signalling molecules in women with and without endometriosis, and on the potential roles of TGF-β signalling in the development and progression of peritoneal endometriosis. The current understanding of the TGF-β signalling pathway is summarized. SEARCH METHODS: We searched the Pubmed database using the terms 'transforming growth factor beta' and 'endometriosis' for studies published between 1995 and 2016. The initial search identified 99 studies and these were used as the basic material for this review. We also extended our remit for important older publications. In addition, we searched the reference lists of studies used in this review for additional studies we judged as relevant. Studies which were included in the review focused on peritoneal endometriosis only as increasing evidence suggests that ovarian and deep endometriosis may have a differing pathophysiology. Thus, a final 95 studies were included in the review. OUTCOMES: TGF-β1 is reported to be increased in the peritoneal fluid, serum, ectopic endometrium and peritoneum of women with endometriosis compared to women without endometriosis, and TGF-β1-null mice have reduced endometriosis lesion growth when compared to their wild-type controls. Studies in mice and women have indicated that increasing levels of TGF-β ligands are associated with decreased immune cell activity within the peritoneum, together with an increase in ectopic endometrial cell survival, attachment, invasion and proliferation, during endometriosis lesion development. TGF-β1 has been associated with changes in ectopic endometrial and peritoneal cell metabolism and the initiation of neoangiogenesis, further fuelling endometriosis lesion development. WIDER IMPLICATIONS: Together these studies suggest that TGF-β1 plays a major role in the development of peritoneal endometriosis lesions and that targeting this pathway may be of therapeutic potential.
引用
- Young VJ, Ahmad SF, Duncan WC, et al. The role of TGF-β in the pathophysiology of peritoneal endometriosis. Hum Reprod Update. 2017. PMID: 28903471. doi:10.1093/humupd/dmx016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。